Ross Parfitt

547 total citations
8 papers, 223 citations indexed

About

Ross Parfitt is a scholar working on Sensory Systems, Cognitive Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ross Parfitt has authored 8 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Sensory Systems, 3 papers in Cognitive Neuroscience and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ross Parfitt's work include Hearing, Cochlea, Tinnitus, Genetics (6 papers), Hearing Loss and Rehabilitation (3 papers) and Infant Health and Development (2 papers). Ross Parfitt is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (6 papers), Hearing Loss and Rehabilitation (3 papers) and Infant Health and Development (2 papers). Ross Parfitt collaborates with scholars based in Germany, Switzerland and Ireland. Ross Parfitt's co-authors include Claudia Lanvers‐Kaminsky, Giuliano Ciarimboli, Peter Matulat, Antoinette am Zehnhoff‐Dinnesen, Hans Theodor Eich, Sergiu Scobioala, Nicolas Waespe, Claudia E. Kuehni, Annette Weiß and Marc Ansari and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Journal of Intellectual Disability Research and Pediatric Blood & Cancer.

In The Last Decade

Ross Parfitt

6 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Parfitt Germany 4 118 49 42 38 35 8 223
Yongdong Song China 8 150 1.3× 119 2.4× 100 2.4× 21 0.6× 14 0.4× 19 286
Junyan Gao China 8 115 1.0× 28 0.6× 108 2.6× 12 0.3× 23 0.7× 15 289
Xiaohua Cheng China 9 66 0.6× 27 0.6× 114 2.7× 29 0.8× 32 0.9× 33 238
Sigurd Rauch Germany 9 81 0.7× 77 1.6× 45 1.1× 18 0.5× 9 0.3× 32 278
Natsumi Uehara Japan 11 128 1.1× 67 1.4× 75 1.8× 55 1.4× 37 1.1× 25 252
Fangwei Zhou China 8 26 0.2× 22 0.4× 61 1.5× 10 0.3× 8 0.2× 18 156
Charlotte Van den Eynde Belgium 8 62 0.5× 10 0.2× 68 1.6× 4 0.1× 10 0.3× 10 186
Serge‐Daniel Le Bon Belgium 7 204 1.7× 17 0.3× 52 1.2× 10 0.3× 3 0.1× 10 306
Mitsuo Motobayashi Japan 10 19 0.2× 25 0.5× 62 1.5× 4 0.1× 10 0.3× 35 228
Kohei Nishida Japan 12 111 0.9× 14 0.3× 22 0.5× 2 0.1× 5 0.1× 34 301

Countries citing papers authored by Ross Parfitt

Since Specialization
Citations

This map shows the geographic impact of Ross Parfitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Parfitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Parfitt more than expected).

Fields of papers citing papers by Ross Parfitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Parfitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Parfitt. The network helps show where Ross Parfitt may publish in the future.

Co-authorship network of co-authors of Ross Parfitt

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Parfitt. A scholar is included among the top collaborators of Ross Parfitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Parfitt. Ross Parfitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wasmuth, Susanne, Ross Parfitt, Werner Brannath, et al.. (2025). Evaluating the Hearing‐Related Quality of Life in People With Intellectual Disabilities. Journal of Intellectual Disability Research. 69(12). 1413–1424.
2.
Troschel, Fabian M., Ross Parfitt, Antoinette am Zehnhoff‐Dinnesen, et al.. (2024). Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study. Strahlentherapie und Onkologie. 201(4). 438–451.
3.
Mader, Luzius, Nicolas Waespe, Annette Weiß, et al.. (2022). Severity of hearing loss after platinum chemotherapy in childhood cancer survivors. Pediatric Blood & Cancer. 69(9). e29755–e29755. 7 indexed citations
4.
Matulat, Peter & Ross Parfitt. (2018). The Newborn Hearing Screening Programme in Germany. International Journal of Neonatal Screening. 4(3). 29–29. 10 indexed citations
5.
Scobioala, Sergiu, et al.. (2017). Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing. Strahlentherapie und Onkologie. 193(11). 910–920. 14 indexed citations
6.
Matulat, Peter, P. Böttcher, Ross Parfitt, et al.. (2016). Two-Way Radio Modem Data Transfer for Newborn Hearing Screening Devices. Telemedicine Journal and e-Health. 23(1). 49–54. 1 indexed citations
7.
Lanvers‐Kaminsky, Claudia, et al.. (2016). Drug‐induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies. Clinical Pharmacology & Therapeutics. 101(4). 491–500. 190 indexed citations
8.
Parfitt, Ross, et al.. (2008). Using Cs-137, C-14 and biomarker compounds to identify reasons for C and N losses in resampled profiles. AGU Fall Meeting Abstracts. 2008. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026